(dp1
S'limited'
p2
F0.010508
sS'selection'
p3
F0.025957999999999998
sS'help'
p4
F0.0045960000000000003
sS'able'
p5
F0.0071640000000000002
sS'insight'
p6
F0.0030739999999999999
sS'existing'
p7
F0.0096530000000000001
sS'leads'
p8
F0.02691
sS'course'
p9
F0.0072659999999999999
sS'manager'
p10
F0.0045929999999999999
sS'including'
p11
F0.005875
sS'seamless'
p12
F0.012985
sS'aspect'
p13
F0.0058840000000000003
sS'live longer better'
p14
F0.015172
sS'portfolio'
p15
F0.0062310000000000004
sS'gender identity'
p16
F0.0083730000000000002
sS'talented people'
p17
F0.011317000000000001
sS'discipline'
p18
F0.0056829999999999997
sS'execution'
p19
F0.010544
sS'group'
p20
F0.0041089999999999998
sS'knowledge'
p21
F0.0042560000000000002
sS'candidate'
p22
F0.0043280000000000002
sS'applicable national'
p23
F0.014590000000000001
sS'translational research'
p24
F0.016466999999999999
sS'acting'
p25
F0.011802999999999999
sS'clinical biomarker assay'
p26
F0.019675999999999999
sS'age'
p27
F0.0082039999999999995
sS'theme'
p28
F0.013738999999999999
sS'program'
p29
F0.021735000000000001
sS'translational medicine'
p30
F0.018072000000000001
sS'passion'
p31
F0.0045120000000000004
sS'include'
p32
F0.0043249999999999999
sS'presentation'
p33
F0.0044270000000000004
sS'within'
p34
F0.0027789999999999998
sS'assay'
p35
F0.016466999999999999
sS'combination'
p36
F0.012824
sS'drug moas'
p37
F0.019675999999999999
sS'overall'
p38
F0.0056779999999999999
sS'term'
p39
F0.0079279999999999993
sS'early'
p40
F0.010442
sS'quest'
p41
F0.0080929999999999995
sS'working closely'
p42
F0.0079279999999999993
sS'unique'
p43
F0.0060130000000000001
sS'recipient'
p44
F0.016466999999999999
sS'condition'
p45
F0.0089929999999999993
sS'look'
p46
F0.0073769999999999999
sS'execute'
p47
F0.0054840000000000002
sS'solid tumor including'
p48
F0.019675999999999999
sS'investigator'
p49
F0.012985
sS'novel biomarkers'
p50
F0.019675999999999999
sS'future'
p51
F0.0035249999999999999
sS'position description'
p52
F0.0080929999999999995
sS'serves'
p53
F0.011513000000000001
sS'leader'
p54
F0.0036540000000000001
sS'specific'
p55
F0.0050280000000000004
sS'excellence'
p56
F0.0054990000000000004
sS'common'
p57
F0.0074460000000000004
sS'team'
p58
F0.004424
sS'small'
p59
F0.0064879999999999998
sS'complex'
p60
F0.0073359999999999996
sS'identifies'
p61
F0.0086529999999999992
sS'discovery'
p62
F0.0077070000000000003
sS'resistance mechanism'
p63
F0.019675999999999999
sS'solid tumor experience'
p64
F0.039351999999999998
sS'companion diagnostics'
p65
F0.019675999999999999
sS'enhances'
p66
F0.014590000000000001
sS'set'
p67
F0.0049389999999999998
sS'human'
p68
F0.0076940000000000003
sS'formulate'
p69
F0.0090860000000000003
sS'immunological influencers'
p70
F0.019675999999999999
sS'acquired'
p71
F0.015949999999999999
sS'committed'
p72
F0.0037620000000000002
sS'global biopharmaceutical company'
p73
F0.015172
sS'culture'
p74
F0.0047369999999999999
sS'external stakeholder'
p75
F0.010813
sS'rapidly evolving'
p76
F0.012134000000000001
sS'manner'
p77
F0.0076049999999999998
sS'pancreatic cancer'
p78
F0.019675999999999999
sS'beyond'
p79
F0.0073769999999999999
sS'employment'
p80
F0.011131
sS'scientific'
p81
F0.017963
sS'large'
p82
F0.0096080000000000002
sS'identifying opportunity'
p83
F0.0104
sS'matrix'
p84
F0.013566999999999999
sS'expert'
p85
F0.0043959999999999997
sS'significant immune oncology'
p86
F0.019675999999999999
sS'since'
p87
F0.010813
sS'integration'
p88
F0.0051469999999999997
sS'research'
p89
F0.0054650000000000002
sS'numerous'
p90
F0.011317000000000001
sS'state'
p91
F0.011913
sS'support late clinical'
p92
F0.019675999999999999
sS'health'
p93
F0.0055710000000000004
sS'decision making'
p94
F0.0069509999999999997
sS'innovation'
p95
F0.0072269999999999999
sS'mast project'
p96
F0.019675999999999999
sS'new'
p97
F0.0087209999999999996
sS'patient stratification identification'
p98
F0.019675999999999999
sS'protein homeostasis'
p99
F0.019675999999999999
sS'supports'
p100
F0.0093380000000000008
sS'across'
p101
F0.010348
sS'independence'
p102
F0.011256
sS'span io epigenetics'
p103
F0.019675999999999999
sS'cross-functional team'
p104
F0.0071700000000000002
sS'various'
p105
F0.0040010000000000002
sS'patient'
p106
F0.060989000000000002
sS'ability'
p107
F0.0052579999999999997
sS'business'
p108
F0.0031800000000000001
sS'written'
p109
F0.0055919999999999997
sS'innovation spirit'
p110
F0.015172
sS'interfaces'
p111
F0.012225
sS'activity'
p112
F0.0047959999999999999
sS'component'
p113
F0.0066
sS'understanding'
p114
F0.0029750000000000002
sS'late clinical'
p115
F0.039351999999999998
sS'job'
p116
F0.0027560000000000002
sS'leadership'
p117
F0.0039509999999999997
sS'hypothesis'
p118
F0.0090860000000000003
sS'collection'
p119
F0.0079430000000000004
sS'key'
p120
F0.0074190000000000002
sS'address'
p121
F0.0055599999999999998
sS'active'
p122
F0.0087740000000000005
sS'based'
p123
F0.0034299999999999999
sS'including protein homeostasis immune-oncology bio-therapeutics'
p124
F0.019675999999999999
sS'change'
p125
F0.0042170000000000003
sS'advance'
p126
F0.0067080000000000004
sS'pipeline'
p127
F0.0076940000000000003
sS'epigenetics'
p128
F0.019675999999999999
sS'central'
p129
F0.0091350000000000008
sS'working'
p130
F0.0025110000000000002
sS'many'
p131
F0.0057959999999999999
sS'industry'
p132
F0.0026340000000000001
sS'develop therapy'
p133
F0.015172
sS'partnership'
p134
F0.0076940000000000003
sS'experience'
p135
F0.00043199999999999998
sS'guide'
p136
F0.0065360000000000001
sS'collate multi-parameter genomic'
p137
F0.019675999999999999
sS'ensure'
p138
F0.003882
sS'clinical correlative science'
p139
F0.019675999999999999
sS'high quality'
p140
F0.0076810000000000003
sS'70 country'
p141
F0.014862999999999999
sS'focused'
p142
F0.0050949999999999997
sS'implement'
p143
F0.0032759999999999998
sS'without regard'
p144
F0.0077210000000000004
sS'gbm lung'
p145
F0.019675999999999999
sS'relevant'
p146
F0.0042090000000000001
sS'love'
p147
F0.0061760000000000001
sS'interfacing'
p148
F0.012418
sS'biobank sample'
p149
F0.019675999999999999
sS'communication'
p150
F0.0048190000000000004
sS'veteran status'
p151
F0.0072769999999999996
sS'delivering'
p152
F0.0053749999999999996
sS'highly'
p153
F0.010581
sS'celgene'
p154
F0.15171599999999999
sS'regulatory'
p155
F0.028426
sS'conjunction'
p156
F0.009776
sS'clinical'
p157
F0.043991000000000002
sS'translational'
p158
F0.049401
sS'apply'
p159
F0.003251
sS'strategy'
p160
F0.026131000000000001
sS'landscape'
p161
F0.0094470000000000005
sS'identify biobanks clinical trial'
p162
F0.019675999999999999
sS'ensures'
p163
F0.0083040000000000006
sS'management'
p164
F0.0026180000000000001
sS'verbal'
p165
F0.0074939999999999998
sS'research lab'
p166
F0.013117999999999999
sS'area'
p167
F0.0062880000000000002
sS'leading'
p168
F0.0033170000000000001
sS'support'
p169
F0.001585
sS'engagement'
p170
F0.006149
sS'question'
p171
F0.0051729999999999996
sS'downstream phenotypic effect'
p172
F0.019675999999999999
sS'td scientist'
p173
F0.019675999999999999
sS'response'
p174
F0.015855999999999999
sS'priority'
p175
F0.0066829999999999997
sS'celgene complies'
p176
F0.015172
sS'approach'
p177
F0.003803
sS'teamwork'
p178
F0.0070190000000000001
sS'asset'
p179
F0.036060000000000002
sS'maintenance'
p180
F0.006633
sS'basic'
p181
F0.013809
sS'expected'
p182
F0.0065199999999999998
sS'local law governing nondiscrimination'
p183
F0.012225
sS'authorization'
p184
F0.010763999999999999
sS'define'
p185
F0.0046870000000000002
sS'function'
p186
F0.0048760000000000001
sS'head'
p187
F0.0092599999999999991
sS'enable'
p188
F0.0052310000000000004
sS'way'
p189
F0.003493
sS'company'
p190
F0.0023600000000000001
sS'applies knowledge'
p191
F0.012418
sS'interpersonal skill'
p192
F0.008633
sS'oversight'
p193
F0.0094750000000000008
sS'translational development'
p194
F0.078703999999999996
sS'employee'
p195
F0.0041479999999999998
sS'external'
p196
F0.010713
sS'preclinical research'
p197
F0.019675999999999999
sS'delivers'
p198
F0.0082539999999999992
sS'presented'
p199
F0.011880999999999999
sS'holder'
p200
F0.017132999999999999
sS'must'
p201
F0.0064599999999999996
sS'applied'
p202
F0.0057219999999999997
sS'md'
p203
F0.024836
sS'datasets'
p204
F0.0069509999999999997
sS'communicate'
p205
F0.0045180000000000003
sS'nationality act'
p206
F0.014590000000000001
sS'science'
p207
F0.010364
sS'challenge'
p208
F0.0043610000000000003
sS'work'
p209
F0.0024190000000000001
sS'value'
p210
F0.0039560000000000003
sS'lead'
p211
F0.0027980000000000001
sS'project'
p212
F0.011247
sS'li-cb1'
p213
F0.017132999999999999
sS'r'
F0.0034780000000000002
sS'employment eligibility verification requirement'
p214
F0.014590000000000001
sS'disease area'
p215
F0.068531999999999996
sS'growing'
p216
F0.0063379999999999999
sS'demonstrate'
p217
F0.0061760000000000001
sS'liaises'
p218
F0.036143000000000002
sS'applicant'
p219
F0.011696
sS'solid tumor'
p220
F0.039351999999999998
sS'detailed'
p221
F0.0082539999999999992
sS'transition'
p222
F0.0096509999999999999
sS'willingness'
p223
F0.0072329999999999998
sS'process'
p224
F0.002343
sS'well'
p225
F0.0054710000000000002
sS'approved'
p226
F0.012520999999999999
sS'contribute'
p227
F0.0054190000000000002
sS'mine'
p228
F0.0099780000000000008
sS'deep'
p229
F0.011649
sS'direct'
p230
F0.0065360000000000001
sS'race color religion sex sexual orientation'
p231
F0.012985
sS'expertise'
p232
F0.0031150000000000001
sS'drug'
p233
F0.053817999999999998
sS'laboratory'
p234
F0.010357999999999999
sS'need'
p235
F0.0049800000000000001
sS'partner'
p236
F0.0036700000000000001
sS'biology pathophysiology oncogenic microenvironment'
p237
F0.019675999999999999
sS'information'
p238
F0.0053470000000000002
sS'develop'
p239
F0.0018060000000000001
sS'us'
p240
F0.0039050000000000001
sS'phd'
p241
F0.0074330000000000004
sS'presence'
p242
F0.010357999999999999
sS'format'
p243
F0.0075550000000000001
sS'-'
F0.006927
sS'1'
F0.0062589999999999998
sS'also'
p244
F0.0038340000000000002
sS'internal'
p245
F0.0074190000000000002
sS'role'
p246
F0.0024069999999999999
sS'incumbent'
p247
F0.010357999999999999
sS'writer'
p248
F0.01286
sS'target'
p249
F0.015547999999999999
sS'computational biologist data scientist'
p250
F0.018072000000000001
sS'development'
p251
F0.013978000000000001
sS'deeper understanding'
p252
F0.012418
sS'criterion'
p253
F0.012225
sS'description'
p254
F0.0047889999999999999
sS'significant immuno oncology'
p255
F0.019675999999999999
sS'empower'
p256
F0.0088590000000000006
sS'collaboration'
p257
F0.004555
sS'pick'
p258
F0.012741000000000001
sS'qualifications'
p259
F0.0055799999999999999
sS'lab'
p260
F0.0099430000000000004
sS'immigration'
p261
F0.013738999999999999
sS'discover'
p262
F0.0078709999999999995
sS'coordinate'
p263
F0.0070479999999999996
sS'moment'
p264
F0.010357999999999999
sS'commercial'
p265
F0.0129
sS'late phase compound'
p266
F0.019675999999999999
sS'purpose'
p267
F0.0063969999999999999
sS'oversees'
p268
F0.012741000000000001
sS'phase'
p269
F0.017073999999999999
sS'early development thematic center'
p270
F0.019675999999999999
sS'segment'
p271
F0.019618
sS'grow'
p272
F0.0052310000000000004
sS'exposure'
p273
F0.0070479999999999996
sS'unmet need'
p274
F0.049401
sS'iit clinical trial'
p275
F0.019675999999999999
sS'driving'
p276
F0.0056779999999999999
sS'effective'
p277
F0.00513
sS'database'
p278
F0.0034160000000000002
sS'statistician'
p279
F0.0092860000000000009
sS'medical'
p280
F0.0074580000000000002
sS'required'
p281
F0.0022430000000000002
sS'life'
p282
F0.0038270000000000001
sS'disease'
p283
F0.13069500000000001
sS'provide'
p284
F0.0023530000000000001
sS'gap'
p285
F0.008463
sS'academia'
p286
F0.0104
sS'gender expression national origin disability'
p287
F0.014590000000000001
sS'position'
p288
F0.0022750000000000001
sS'validation'
p289
F0.0066579999999999999
sS'interface'
p290
F0.0064349999999999997
sS'equal opportunity'
p291
F0.0084449999999999994
sS'representative'
p292
F0.010123
s.